Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients

Phase 1 Unknown 12 enrolled Jiangsu Hansoh Pharmaceutical Co., Ltd.

NaSingle-groupOpen-labelTreatment

Summary

This study is conducted in China. The aim of this trial is to assess the tolerability to HS-20004 with titration administration in type 2 diabetic patients.

Timeline

Start: 2015-12
Primary completion: 2017-01
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HS-20004	Unknown	0.18 mg	—

Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients

Summary

Timeline

Drugs

Indications